Sr. no. | Therapeutic Category | Product | Pharmacopoeia | Us DMF | EDMW | CEP |
---|---|---|---|---|---|---|
1 | Antigout/ Primary Biliary Cirrhosis | Ursodeoxycholic Acid (UDCA) | USP/ EP/ JP | |||
2 | Lipid Lowering Agent* | Atorvastatin Calcium (Amorphous) Atorvastatin Calcium (Crystalline) |
USP/ EP/ JP USP/ EP/ JP |
|||
3 | Antiplatelet Agent | Clopidogrel Bisulphate (Form I) Clopidogrel Bisulphate (Form II) |
USP/ EP/ JP USP/ EP/ JP |
|||
4 | Antihistamine | Cetirizine Dihydrochloride | USP/ EP | |||
5 | Anti-Cancer | Docetaxel Anhydrous Docetaxel Trihydrate Gemcitabine Hydrochloride Irinotecan Hydrochloride Paclitaxel Hydrochloride |
In-House EP USP/ EP USP USP/ EP |
|||
6 | Expectorant | Bromhexine Hydrochloride | EP/ BP | |||
7 | Antidepressant | Milnacipran | USP/ JP | |||
8 | Anticonvulsant | Felbamate | USP | |||
9 | Antiparkinsonian | Entacapone Benztropine Mesylate |
USP USP |
|||
10 | Antibacterial | Nitrofurantoin | USP | |||
11 | Anesthetic | Prilocaine | USP | |||
12 | Analgesic | Flupirtine Maleate Diclofenac Sodium Mefenamic Acid Meloxicam Piroxicam S (+) Ibuprofen Nabumetone |
USP/ EP/ BP USP/ EP/ BP USP/ EP/ BP USP/ EP USP/ EP In-house USP |
Filed |
Note : All transactions are carried out in conformity with patent laws applicable in the buyer’s country. Responsibility with respect to third party patent rights in a specific country lies exclusively with the buyer.